Changes in quality standards and analytical methods of terazosin tablets and APIs:<br>1. It is planned to remove heavy metals from API quality standards and analysis methods;<br>2. It is planned to add chromatographic identification a and related substance detection to the quality standard of finished products, identification confirmation instructions under the item of properties, and laboratory address in the COA of products;<br>3. It is planned to delete the hardness test items in the stability quality standard, revise the name of degradation products to related substances, and name the known impurities 4-amino-6, 7-dimethoxy-2 (1-piperazinyl) quinazoline as terazosin related compound a limit from 0.5% to 0.4%, add two known impurities control, and add identification confirmation instructions under the property item;<br>4. It is planned to add UV identification to the analysis method, revise relevant substance items and delete hardness test. "<br>
正在翻译中..